Can Trulicity (Dulaglutide) Cause Erectile Dysfunction?
Medically reviewed by Alan Lucks | MD, Alan Lucks MDPC Private Practice - New York on July 17th, 2026.
Published on July 15th, 2026. Updated on July 17th, 2026.
Key takeaways
Erectile dysfunction is not an officially labeled side effect of dulaglutide (Trulicity), but the concern is understandable given the population most likely to take it.
Type 2 diabetes itself is one of the strongest known risk factors for ED, affecting up to 75% of men with the condition, which makes it difficult to blame the medication alone.
GLP-1 therapy may actually improve erectile function over time through better blood sugar control, meaningful weight loss, and cardiovascular benefits.
Short-term side effects like nausea and fatigue can indirectly affect sexual performance without representing a true pharmacological cause of ED.
Men who notice changes in sexual function after starting dulaglutide should seek a full evaluation rather than stopping the medication on their own.
What Dulaglutide Is and Why This Question Matters
Dulaglutide, sold under the brand name Trulicity, is a GLP-1 receptor agonist approved for managing type 2 diabetes and reducing cardiovascular risk. It works by mimicking natural incretin hormones to stimulate insulin release, slow digestion, and curb appetite. It is commonly prescribed alongside metformin, and some clinicians also use it off-label to support weight loss.
Men make up a large share of the type 2 diabetes population, and many of them are already navigating concerns about sexual health before they ever fill a Trulicity prescription. So when erectile dysfunction appears or worsens after starting the medication, it is entirely reasonable to wonder whether the drug is to blame. The honest answer requires looking at several overlapping factors.
What the Official Label Does and Does Not Say
Erectile dysfunction does not appear anywhere in Trulicity's FDA prescribing information as a recognized adverse effect. The side effects listed most frequently in clinical trials are gastrointestinal: nausea, diarrhea, vomiting, and abdominal discomfort. These are the reactions the drug is best known for.
However, the absence of ED from the label does not completely settle the question. Post-marketing surveillance and patient-reported outcomes sometimes reveal signals that were not captured in controlled trials, particularly when the affected population already carries a very high baseline risk for a given condition. That nuance matters a great deal here.
The Diabetes Connection That Complicates Attribution
Here is the central challenge: type 2 diabetes is itself one of the most powerful risk factors for erectile dysfunction in men. Research consistently estimates that between 50% and 75% of men with type 2 diabetes experience ED at some point, often years before a formal diabetes diagnosis is made.
Chronic high blood sugar damages the endothelial cells lining blood vessels and injures peripheral nerves, both of which are essential for normal erections. Poor glycemic control also contributes to low-grade inflammation and metabolic dysfunction that can suppress testosterone indirectly. This means ED that surfaces around the time a man starts dulaglutide may well predate the medication entirely, or stem from the disease rather than the drug.
Other common confounders include medications frequently prescribed alongside dulaglutide. Antihypertensives, certain antidepressants, and even metformin have associations with sexual side effects in some men. A full medication review is always a useful starting point.
Ways GLP-1 Therapy May Actually Support Erectile Function
Countering the concern, there is a reasonable case that dulaglutide may benefit sexual health over time rather than harm it.
Better blood sugar control reduces the ongoing vascular and nerve damage that drives diabetic ED. Weight loss, which is a common outcome of GLP-1 therapy, raises free testosterone levels and improves arterial blood flow, including to the penis. The REWIND cardiovascular outcomes trial demonstrated meaningful reductions in major cardiovascular events with dulaglutide, which over time supports healthier penile circulation.
Perhaps most intriguing, early-stage research suggests that GLP-1 receptors may exist in penile tissue and could play a direct role in erectile function. This evidence is still preliminary and should not be overstated, but it adds another layer to what is already a complicated picture.
Possible Causes of ED in Men Taking Dulaglutide
The table below summarizes the most common explanations for ED in this population and what might be done about each one.
Cause |
Relationship to Dulaglutide |
Action to Consider |
|---|---|---|
Underlying type 2 diabetes |
Unrelated to the drug; present before or independent of treatment |
Optimize glycemic control; request HbA1c and testosterone testing |
GLP-1 side effects (nausea, fatigue) |
Indirect; reduced energy and libido, not a pharmacological ED mechanism |
Often improves after the first few weeks as the body adjusts |
Caloric restriction during early treatment |
Indirect; temporary hormonal and energy fluctuations |
Usually self-resolving; monitor diet for adequate nutrition |
Psychological stress of new diagnosis |
Unrelated to the drug; situational and anxiety-driven |
Counseling, stress management, or sex therapy may help |
Concurrent medications (antihypertensives, antidepressants) |
Unrelated to dulaglutide but an important confounder |
Request a full medication review with your prescriber |
Low testosterone |
May worsen with poor diabetes control; unrelated to GLP-1 directly |
Request testosterone panel; discuss treatment options if low |
When to Raise This with a Clinician and What to Bring Up
If ED began or noticeably worsened shortly after starting dulaglutide, that timing is worth discussing with a prescriber. It does not prove causation, but it opens a productive conversation.
A thoughtful evaluation should include testosterone levels, a current HbA1c, blood pressure readings, and a review of every medication being taken. From there, a clinician can determine whether adjusting the dulaglutide dose, switching to a different GLP-1 agent, or adding an ED-specific treatment is the right path forward.
PDE5 inhibitors such as sildenafil and tadalafil are generally considered safe alongside dulaglutide, though men on antihypertensive medications should flag this to their provider because of potential blood pressure interactions. Lifestyle changes, including regular physical activity, improved sleep, and reduced alcohol intake, remain foundational to both diabetes management and erectile health.
Doctronic, which has completed more than 22 million AI consultations with a 99.2% treatment plan alignment with board-certified physicians, offers a private and affordable way for men to organize their symptoms and prepare for exactly this kind of conversation. Free AI consultations and $39 video visits are available around the clock, making it easier to get answers without waiting weeks for an appointment.
Frequently Asked Questions
No. Erectile dysfunction does not appear in Trulicity's FDA prescribing information. The documented side effects are primarily gastrointestinal, including nausea, diarrhea, and vomiting. That said, absence from the official label does not completely rule out a real-world connection, particularly in men who already face a high baseline risk of ED due to diabetes.
Possibly, yes. Improved blood sugar control reduces vascular and nerve damage linked to diabetic ED. Weight loss associated with GLP-1 therapy may raise free testosterone and improve blood flow. Early research also suggests GLP-1 receptors in penile tissue may play a direct role in erectile function, though this evidence is still preliminary and more studies are needed.
Timing is a helpful clue. If ED began or clearly worsened shortly after starting dulaglutide, the medication or its side effects may be a contributing factor. However, because up to 75% of men with type 2 diabetes experience ED related to the disease itself, a full workup including testosterone levels, HbA1c, blood pressure, and a medication review is the best way to identify the actual cause.
PDE5 inhibitors like sildenafil (Viagra) and tadalafil (Cialis) are generally considered compatible with dulaglutide. However, men with diabetes often also take antihypertensive medications, which can interact with PDE5 inhibitors and lower blood pressure significantly. Nitrates are not to be taken with PDE5 inhibitors. Always review your complete medication list with a clinician before starting any ED treatment.
No, not without talking to your prescriber first. Stopping dulaglutide abruptly can worsen blood sugar control and increase cardiovascular risk. A clinician can help determine whether the medication is truly the cause, adjust the dose, explore alternative GLP-1 agents, or add effective ED treatments that work safely alongside your current regimen.
The Bottom Line
Dulaglutide (Trulicity) is unlikely to directly cause erectile dysfunction and may actually support better sexual health over time by improving blood sugar control, promoting weight loss, and reducing cardiovascular risk. The more probable culprit in most cases is the underlying type 2 diabetes, which damages the blood vessels and nerves essential for normal erections. That said, short-term side effects and the stress of a new diagnosis can play a real role in situational ED. Men deserve a thorough answer, not dismissal. Doctronic offers free AI consultations and $39 video visits available 24/7, giving men a private, affordable way to organize their symptoms and get a clear path forward. This article is informational and is not a medical diagnosis. Confirm with a licensed clinician, especially for new, worsening, or high-risk symptoms.
Related articles
Get medical advice
Chat Now